How immunosuppressive therapy affects T cells from kidney transplanted patients of different age: The role of latent cytomegalovirus infection

Clinical and Experimental Immunology

Volumn 176, Issue 1, 2014, Pages 112-119

  Welzl, K ^a,b   Weinberger, B ^a   Kronbichler, A ^b   Sturm, G ^b   Kern, G ^b   Mayer, G ^b   Grubeck Loebenstein, B ^a   Koppelstaetter, C ^b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Ageing; Immunosuppressive therapy; T cells

Indexed keywords

AZATHIOPRINE; CD28 ANTIGEN; CHEMOKINE RECEPTOR CXCR5; CORTISONE; CYCLOSPORIN A; EVEROLIMUS; GAMMA INTERFERON; INTERLEUKIN 2; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; AGED; ARTICLE; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; EFFECTOR CELL; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LATENT VIRUS INFECTION; MIDDLE AGED; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

AGEING; IMMUNOSUPPRESSIVE THERAPY; T CELLS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; INTERLEUKIN-2; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RECEPTORS, CXCR5; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TIME FACTORS;

EID: 84895558823     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12205     Document Type: Article

References (40)

1. Cohen DJ, St Martin L, Christensen LL, Bloom RD, Sung RS. Kidney and pancreas transplantation in the United States, 1995-2004. Am J Transplant 2006; 6:1153-1169.
2. Danovitch GM, Cohen DJ, Weir MR etal. Current status of kidney and pancreas transplantation in the United States, 1994-2003. Am J Transplant 2005; 5:904-915.
3. Meier-Kriesche HU, Port FK, Ojo AO etal. Effect of waiting time on renal transplant outcome. Kidney Int 2000; 58:1311-1317.
4. Oniscu GC, Brown H, Forsythe JL. Impact of cadaveric renal transplantation on survival in patients listed for transplantation. J Am Soc Nephrol 2005; 16:1859-1865.
5. Wolfe RA, Ashby VB, Milford EL etal. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341:1725-1730.
6. Frei U, Noeldeke J, Machold-Fabrizii V etal. Prospective age-matching in elderly kidney transplant recipients - a 5-year analysis of the Eurotransplant Senior Program. Am J Transplant 2008; 8:50-57.
7. Franceschi C, Bonafe M, Valensin S. Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine 2000; 18:1717-1720.
8. Targonski PV, Jacobson RM, Poland GA. Immunosenescence: role and measurement in influenza vaccine response among the elderly. Vaccine 2007; 25:3066-3069.
9. Weinberger B, Grubeck-Loebenstein B. Vaccines for the elderly. Clin Microbiol Infect 2012; 18 (Suppl. 5):100-108.
10. Weinberger B, Weiskopf D, Grubeck-Loebenstein B. Immunology and aging. In: Halter J, Ed. Hazzard's geriatric medicine and gerontology. Columbus, OH: McGraw Hill, 2009; 23-36.
11. George AJ, Ritter MA. Thymic involution with ageing: obsolescence or good housekeeping? Immunol Today 1996; 17:267-272.
12. Effros RB, Cai Z, Linton PJ. CD8 T cells and aging. Crit Rev Immunol 2003; 23:45-64.
13. Fagnoni FF, Vescovini R, Passeri G etal. Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging. Blood 2000; 95:2860-2868.
14. Goronzy JJ, Weyand CM. T cell development and receptor diversity during aging. Curr Opin Immunol 2005; 17:468-475.
15. Pfister G, Weiskopf D, Lazuardi L etal. Naive T cells in the elderly: are they still there? Ann NY Acad Sci 2006; 1067:152-157.
16. Arnold CR, Wolf J, Brunner S, Herndler-Brandstetter D, Grubeck-Loebenstein B. Gain and loss of T cell subsets in old age - age-related reshaping of the T cell repertoire. J Clin Immunol 2011; 31:137-146.
17. Cicin-Sain L, Smyk-Pearson S, Currier N etal. Loss of naive T cells and repertoire constriction predict poor response to vaccination in old primates. J Immunol 2010; 184:6739-6745.
18. Naylor K, Li G, Vallejo AN etal. The influence of age on T cell generation and TCR diversity. J Immunol 2005; 174:7446-7452.
19. Yager EJ, Ahmed M, Lanzer K, Randall TD, Woodland DL, Blackman MA. Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus. J Exp Med 2008; 205:711-723.
20. Brunner S, Herndler-Brandstetter D, Weinberger B, Grubeck-Loebenstein B. Persistent viral infections and immune aging. Ageing Res Rev 2011; 10:362-369.
21. Pawelec G, Derhovanessian E. Role of CMV in immune senescence. Virus Res 2011; 157:175-179.
22. Almanzar G, Schwaiger S, Jenewein B etal. Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J Virol 2005; 79:3675-3683.
23. Giakoustidis D, Antoniadis A, Fouzas I etal. Prevalence and clinical impact of cytomegalovirus infection and disease in renal transplantation: ten years of experience in a single center. Transplant Proc 2012; 44:2715-2717.
24. Mouloudi E, Massa E, Georgiadou E etal. Infections related to renal transplantation requiring intensive care admission: a 20-year study. Transplant Proc 2012; 44:2721-2723.
25. Gill J, Sampaio M, Gill JS etal. Induction immunosuppressive therapy in the elderly kidney transplant recipient in the United States. Clin J Am Soc Nephrol 2011; 6:1168-1178.
26. Meier-Kriesche HU, Li S, Gruessner RW etal. Immunosuppression: evolution in practice and trends, 1994-2004. Am J Transplant 2006; 6:1111-1131.
27. Oestreich KJ, Mohn SE, Weinmann AS. Molecular mechanisms that control the expression and activity of Bcl-6 in TH1 cells to regulate flexibility with a TFH-like gene profile. Nat Immunol 2012; 13:405-411.
28. Weinberger B, Lazuardi L, Weiskirchner I etal. Healthy aging and latent infection with CMV lead to distinct changes in CD8+ and CD4+ T-cell subsets in the elderly. Hum Immunol 2007; 68:86-90.
29. Brunner S, Herndler-Brandstetter D, Arnold CR etal. Upregulation of miR-24 is associated with a decreased DNA damage response upon etoposide treatment in highly differentiated CD8(+) T cells sensitizing them to apoptotic cell death. Aging cell 2012; 11:579-587.
30. Herndler-Brandstetter D, Landgraf K, Jenewein B etal. Human bone marrow hosts polyfunctional memory CD4+ and CD8+ T cells with close contact to IL-15-producing cells. J Immunol 2011; 186:6965-6971.
31. Herndler-Brandstetter D, Landgraf K, Tzankov A etal. The impact of aging on memory T cell phenotype and function in the human bone marrow. J Leukoc Biol 2012; 91:197-205.
32. Thewissen M, Somers V, Hellings N, Fraussen J, Damoiseaux J, Stinissen P. CD4+CD28null T cells in autoimmune disease: pathogenic features and decreased susceptibility to immunoregulation. J Immunol 2007; 179:6514-6523.
33. Alber HF, Duftner C, Wanitschek M etal. Neopterin, CD4+CD28- lymphocytes and the extent and severity of coronary artery disease. Int J Cardiol 2009; 135:27-35.
34. Duftner C, Seiler R, Klein-Weigel P etal. High prevalence of circulating CD4+CD28- T-cells in patients with small abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2005; 25:1347-1352.
35. Schirmer M, Duftner C, Seiler R, Dejaco C, Fraedrich G. Abdominal aortic aneurysms: an underestimated type of immune-mediated large vessel arteritis? Curr Opin Rheumatol 2006; 18:48-53.
36. Baeten D, Louis S, Braud C etal. Phenotypically and functionally distinct CD8+ lymphocyte populations in long-term drug-free tolerance and chronic rejection in human kidney graft recipients. J Am Soc Nephrol 2006; 17:294-304.
37. Betjes MG, Meijers RW, de Wit EA, Weimar W, Litjens NH. Terminally differentiated CD8+ Temra cells are associated with the risk for acute kidney allograft rejection. Transplantation 2012; 94:63-69.
38. Li P, Tian C, Ge N etal. Premature senescence of T cells in long-term survivors of renal transplantation. Biochem Biophys Res Commun 2011; 407:599-604.
39. Courivaud C, Bamoulid J, Gaugler B etal. Cytomegalovirus exposure, immune exhaustion and cancer occurrence in renal transplant recipients. Transpl Int 2012; 25:948-955.
40. Andrassy J, Hoffmann VS, Rentsch M etal. Is cytomegalovirus prophylaxis dispensable in patients receiving an mTOR inhibitor-based immunosuppression? A systematic review and meta-analysis. Transplantation 2012; 94:1208-1217.